Cosmos Health receives $4 stock price target from Taglich Brothers, indicating potential growth.

Cosmos Health Inc. (COSM) has received a $4 stock price target from Taglich Brothers, reflecting significant growth potential as the company expands into a vertically integrated global health organization. The firm forecasts FY2024 revenue of $56.3 million, rising 22.6% to $69 million in FY2025, with anticipated operating profit and cash earnings. CEO Greg Siokas supports the target, citing strategic investments driving growth.

September 17, 2024
4 Articles